CD8A and type 1 diabetes mellitus: Collectively, these data indicated that LNT treatment led to potent enhancement in Treg cell frequency and reduction in Th1 cells and CD8 + IFN-γ + T cells in vivo, conferring protection to NOD mice against T1D.